 
                  
Novavax applies for WHO’s EUL listing
Novavax Inc, a vaccine producer, announced on Thursday that it had completed the World Health Organization's emergency use listing process for its COVID-19 vaccine.
Stay updated with the latest news and articles about Novavax.
 
                  
Novavax Inc, a vaccine producer, announced on Thursday that it had completed the World Health Organization's emergency use listing process for its COVID-19 vaccine.
 
                  
The Vaccine issue has grown ever since it was announced that the unvaccinated players will not get special dispensation for the Australian Open.
 
                  
Pfizer’s share price surged 6% on Tuesday to reach a record high of $48.57. The pharmaceutical company surpassed its previous record of $47.39, which was reached in 1999.
 
                  
The statement added that the study enrolled at least 29,960 candidates across 119 sites in the US and Mexico to evaluate efficacy, safety and immunogenicity of the vaccine. Novavax said that the Covovax vaccine had showed 93 per cent efficacy against predominantly circulating variants of concern and the variants of interest.
 
                  
 
                  
 
                  
Showing 15 of 164,386 articles
